Brief: Shilpa Medicare Says Received CEP From EDQM For API, Octreotide
18/11/2024 11:33
Nov 18 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA MEDICARE - RECEIVED CEP FROM EDQM FOR API,
OCTREOTIDE
* SHILPA MEDICARE - UNIT GOT CERTIFICATE OF SUITABILITY FROM
EDQM
Further company coverage: SHME.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026